TribLIVE

| Home


Weather Forecast
 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. Steelers to bring LB Harrison out of retirement
  2. Steelers defense must replace three injured starters after victory
  3. Pitt’s potent rushing attack could slow down the passing game
  4. Pittsburgh Fashion Week 2014 opens to sold-out crowd on South Side
  5. Penguins boast several good blueliners with point-producing skills
  6. Liriano, McCutchen help Pirates to 1-0 win over Braves
  7. Existing home sales fall in August, snapping streak of gains
  8. Business roundup: 10M units of latest iPhone sold in 1st weekend; GM ignition switch death count rises to 21; more
  9. Pirates notebook: Volquez open to re-signing with team
  10. Taxes at forefront of 1st Pa. governor debate between Corbett, Wolf
  11. Winston: Lessons obviously  not learned
Subscribe today! Click here for our subscription offers.